With Alpha Anstalt probably holding over 500k-600k shares still (including series C converts), I don't see any great upside if they funnel their shares out into the market as they have the last year or so around that approximate $1 level. Maybe Feb Q report will show operational profits compared to last year's loss. Hopefully margins start firming fairly soon in next couple Qs. That could help bridge us to potentially more meaningful growth assuming AMPV can ramp up before long.
Will be nice to put them (Alpha) behind us eventually. They seem less willing to sell down to where I'd continue accumulating but I have enough of a chunk to keep fairly close watch on the company going fwd. Kinda reminds me a little bit of SMID in early 2016. Company has had a tough industry environment for years, some competitors have gone BK, company has clean balance sheet and trades slightly under tangible book (minus warrant liabs which I consider a wash given exercise price), company has potential growth drivers coming in a year or so (for SMID it involved patiently waiting for state legislative funding and FAST Act money to funnel thru which happened more in earnest in 2017 on). For OPXS, we still need to see fed funding appropriated. Hopefully that gets taken care of to some extent in the fairly near term. Last Q was disappointing on margins, but that too may resemble SMID where they had good revs but real weak margins early in 2016 working off some older contract work before getting newer stuff at potentially a bit better margins going.
All IMO only.